RSS Feed for Biotech, Pharmaceutical and Clinical Research News | BioSpace (Generated by New Sloth)
Updated: 8 hours 25 min ago
Fri, 05/19/2023 - 02:00
AbbVie Adds Crohn’s Disease to Rinvoq’s Growing List of Indications 5/19/2023
Fri, 05/19/2023 - 02:00
FDA Panel Backs Pfizer’s Maternal RSV Vaccine Despite Safety Concerns 5/19/2023
Fri, 05/19/2023 - 02:00
FDA Approves Bausch + Lomb, Novaliq Dry Eye Disease Drug 5/19/2023
Wed, 05/17/2023 - 02:00
Roche’s MS Drug Hits Phase II Mark, Rivals Remain Under Clinical Holds 5/17/2023
Wed, 05/17/2023 - 02:00
Lilly’s Prevail, Doudna’s Scribe Partner on Genetic Treatments for Neuro Diseases 5/17/2023
Wed, 05/17/2023 - 02:00
PTC Touts Promising Late-Stage Results in Adults, Children with PKU 5/17/2023
Wed, 05/17/2023 - 02:00
CVS Health Winding Down Clinical Trial Business 5/17/2023
Wed, 05/17/2023 - 02:00
Athenex Files for Bankruptcy, Cuts 123 Jobs Across New York 5/17/2023
Wed, 05/17/2023 - 02:00
Biotech Companies in San Francisco Hiring Now 5/17/2023
Mon, 05/15/2023 - 02:00
Lilly-Backed Nido Biosciences Launches with $109M to Target Neurological Diseases 5/15/2023
Mon, 05/15/2023 - 02:00
Astellas Wins FDA Approval for Hot Flash Treatment in Menopausal Women 5/15/2023
Mon, 05/15/2023 - 02:00
AstraZeneca Expands ADC Portfolio with $600M Deal with LaNova 5/15/2023
Mon, 05/15/2023 - 02:00
Companies Bank on Psychedelics as Treatments for Mental Health Disorders 5/15/2023
Mon, 05/15/2023 - 02:00
Therapies for Rare Mitochondrial Diseases Begin to See Traction 5/15/2023
Mon, 05/15/2023 - 02:00
FDA Action Alert: Krystal, Genmab/AbbVie, Pfizer and Intercept 5/15/2023
Sat, 05/13/2023 - 02:00
Sarepta’s Duchenne Therapy Recommended for Accelerated Approval 5/13/2023
Fri, 05/05/2023 - 02:00
Regeneron Diversifies Portfolio as Eylea Revenue Takes a Hit 5/5/2023
Fri, 05/05/2023 - 02:00
AstraZeneca, Pfizer Top 2023 Pharma List for Invention and Innovation 5/5/2023
Fri, 05/05/2023 - 02:00
Novo Nordisk’s Hemophilia Hopeful Hits FDA Roadblock, Company Cuts Wegovy Supply 5/5/2023
Fri, 05/05/2023 - 02:00
Biogen, Novartis, Sanofi Cull Candidates in Q1 Pipeline Reprioritizations 5/5/2023